Home›Search›Advances in Alzheimer's Disease

Advances in Alzheimer's Disease

IOS Press BV · Netherlands · Est. 2011

ISSN2210-5735

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.102

H-Indexi

Total Worksi

438

Total Citationsi

379

2yr Mean Citednessi

0.18

Open Impact Factor alternative

Aims & Scope

Subject areas: Neurology (clinical).

General Information

Country / RegionNetherlands

Primary Language—

1st Year Published2011

Annual Volume~ 56 articles / year

StatusActive (last: 2024)

Total Publications438

Publisher OrgIOS Press

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

IOS Press BV

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2210-5735

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2013

2015

2017

2018

2020

104

2021

112

2022

2024

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Neurology (clinical)Q4

Subject Classification

Scopus Categories

Neurology (clinical)

Research Topics (OpenAlex)

Alzheimer's disease research and treatmentsHealth, Environment, Cognitive AgingDementia and Cognitive Impairment ResearchTryptophan and brain disordersAir Quality and Health ImpactsDiet and metabolism studiesGut microbiota and healthFunctional Brain Connectivity StudiesTraumatic Brain Injury and Neurovascular DisturbancesComputational Drug Discovery Methods

Frequently asked questions about Advances in Alzheimer's Disease

Is Advances in Alzheimer's Disease a predatory journal?

PubScope has no integrity flags on record for Advances in Alzheimer's Disease: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Advances in Alzheimer's Disease?

Advances in Alzheimer's Disease is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.102.

Is Advances in Alzheimer's Disease indexed in Scopus and Web of Science?

Advances in Alzheimer's Disease is indexed in Scopus.

What is the aims and scope of Advances in Alzheimer's Disease?